CONTACT
+91 80 2808 2808
info@biocon.com

News - Posts

Biocon  /  News – Posts

Biocon Biologics and Civica Expand Partnership and Launch Private-Label Insulin Glargine to Broaden U.S. Diabetes Treatment Options
  • Thu, 16-Oct-2025
  • Posted by: BIOCON
No Comments

Company Statement on Biocon’s Cranbury, New Jersey Manufacturing Site
  • Sat, 11-Oct-2025
  • Posted by: BIOCON
No Comments

Biocon Pharma Limited Secures U.S. FDA Tentative Approval for Rifaximin Tablets in Partnership with Carnegie Pharmaceuticals
  • Tue, 07-Oct-2025
  • Posted by: BIOCON
No Comments

Biocon Biologics Secures U.S. Market Entry Date for Bosaya™ and Aukelso™, Denosumab Biosimilars
  • Wed, 01-Oct-2025
  • Posted by: BIOCON
No Comments

Anekal Education Summit 2025 to Chart Vision 2030 to Fulfill Classroom Dreams of Students
  • Fri, 26-Sep-2025
  • Posted by: BIOCON
No Comments

Biocon Biologics’ Yesafili® (aflibercept) Now Publicly Funded in Ontario, Canada for the Advanced Treatment of Patients with Retinal Diseases
  • Thu, 18-Sep-2025
  • Posted by: BIOCON
No Comments

Biocon Biologics Receives U.S. Food and Drug Administration Approval for Bosaya™ and Aukelso™, Denosumab Biosimilars
  • Wed, 17-Sep-2025
  • Posted by: BIOCON
No Comments

Biocon Foundation Supports Government High School, Kicks off Construction of a New Building for 250 Students
  • Fri, 12-Sep-2025
  • Posted by: BIOCON
No Comments

Biocon Inaugurates First U.S. Manufacturing Facility in Cranbury, New Jersey
  • Thu, 11-Sep-2025
  • Posted by: BIOCON
No Comments

U.S. FDA Completes Inspection at Biocon Biologics’ Facility at Biocon Campus, Bengaluru, India
  • Thu, 04-Sep-2025
  • Posted by: BIOCON
No Comments

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2026, Biocon. All Rights Reserved
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>